denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Program: Scientific Workshops
Session: New Scientific Discoveries
Disclosures: Czechowicz: Beam Therapeutics: Current equity holder in publicly-traded company; Decibel Therapeutics: Divested equity in a private or publicly-traded company in the past 24 months, Patents & Royalties: Patent, no royalties; Editas Medicine: Current equity holder in publicly-traded company, Patents & Royalties: Patent, no royalties; Jasper Therapeutics: Patents & Royalties, Research Funding; Global Blood Therapeutics: Divested equity in a private or publicly-traded company in the past 24 months; Magenta Therapeutics: Divested equity in a private or publicly-traded company in the past 24 months, Patents & Royalties; Prime Medicine: Consultancy, Current equity holder in publicly-traded company, Membership on an entity's Board of Directors or advisory committees; Rocket Pharma: Research Funding; Spotlight Therapeutics: Consultancy, Current holder of stock options in a privately-held company; Teiko Bio: Current holder of stock options in a privately-held company; Inograft Therapeutics: Consultancy, Current holder of stock options in a privately-held company, Membership on an entity's Board of Directors or advisory committees, Patents & Royalties; STRM.Bio: Research Funding.
See more of: Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
See more of: Scientific Workshops